8-K - Nuo Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Financing

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On January 21, 2026, Nuo Therapeutics, Inc. (the “Company”) entered into a Loan and Security Agreement (the “Loan Ag

Material Agreement

$1.6M$1.0M$600.0K$200.0K

Source Document

2.03

. Item 3.02 Unregistered Sale of Equity Securities. To the extent required by Item 3.02 of Form 8-K, the information contained in Item 1.01 of this Current Repo

Financing

9.01

Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 4.1 Form of Initial Warrants 4.2 Form of Second Warrants 4.3 Form of Prepayment Warrants

Exhibits Only

Exhibits (6)

10.1

EXHIBIT 10.1

4.1

EXHIBIT 4.1 FORM OF INITIAL WARRANT

4.2

EXHIBIT 4.2 FORM OF SECOND WARRANT

4.3

EXHIBIT 4.3 FORM OF PREPAYMENT WARRANT

4.4

EXHIBIT 4.4 FORM OF INTEREST WARRANT

8-K

FORM 8-K